BIOLINE

About BIOLINE

BioLineRx (Nasdaq: BLRX) is a clinical-stage pharmaceutical company focused on oncology. In early 2026, the company continues the global commercialization of its lead product for stem-cell mobilization, following successful joint ventures and record clinical data in solid tumor treatments.